These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33992586)

  • 1. The evolving profile of cognitive pharmaceutical services in Australia.
    Tong V; Krass I; Luckie K; Aslani P
    Res Social Adm Pharm; 2022 Mar; 18(3):2529-2537. PubMed ID: 33992586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in-depth examination of funded and unfunded cognitive pharmaceutical services.
    Tong V; Krass I; Aslani P
    Explor Res Clin Soc Pharm; 2021 Sep; 3():100060. PubMed ID: 35480617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations of Australian community pharmacists in the provision and implementation of cognitive pharmacy services: a qualitative study.
    Yong FR; Hor SY; Bajorek BV
    BMC Health Serv Res; 2021 Sep; 21(1):906. PubMed ID: 34479542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How does the general public balance convenience and cognitive pharmaceutical services in community pharmacy practice.
    van de Pol JM; van Dijk L; Koster ES; de Jong J; Bouvy ML
    Res Social Adm Pharm; 2021 Mar; 17(3):606-612. PubMed ID: 32534955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Inverse Care Law might not apply to preventative health services in community pharmacy.
    Zonneveld S; Versace VL; Krass I; Clark RA; Shih S; Detert Oude Weme S; Mc Namara KP
    Res Social Adm Pharm; 2021 May; 17(5):875-884. PubMed ID: 33092979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How community pharmacists prioritize cognitive pharmaceutical services.
    van de Pol JM; Koster ES; Hövels AM; Bouvy ML
    Res Social Adm Pharm; 2019 Sep; 15(9):1088-1094. PubMed ID: 30429104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative assessment of a community pharmacy cognitive pharmaceutical services program, using a work system approach.
    Chui MA; Mott DA; Maxwell L
    Res Social Adm Pharm; 2012; 8(3):206-16. PubMed ID: 21824822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded practice in rural community pharmacy: a macro-, meso and micro-level perspective.
    Taylor S; Cairns A; Glass B
    Rural Remote Health; 2021 Jul; 21(3):6158. PubMed ID: 34304577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Providing patient care in community pharmacies in Australia.
    Benrimoj SI; Roberts AS
    Ann Pharmacother; 2005 Nov; 39(11):1911-7. PubMed ID: 16219897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan.
    Hashmi FK; Hassali MA; Khalid A; Saleem F; Aljadhey H; Babar ZUD; Bashaar M
    BMC Health Serv Res; 2017 Jul; 17(1):500. PubMed ID: 28724411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervention research to enhance community pharmacists' cognitive services: a systematic review.
    Patwardhan PD; Amin ME; Chewning BA
    Res Social Adm Pharm; 2014; 10(3):475-93. PubMed ID: 24071523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study.
    Abousheishaa AA; Sulaiman AH; Huri HZ; Kamis SFB; Hamidi H; Ang WC; Zainal ZAB; Shamsuddin N; Guan NC
    BMC Health Serv Res; 2022 Mar; 22(1):321. PubMed ID: 35264175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacy cognitive services during the COVID-19 pandemic: A descriptive study of practices, precautions taken, perceived enablers and barriers and burnout.
    Okuyan B; Bektay MY; Kingir ZB; Save D; Sancar M
    Int J Clin Pract; 2021 Dec; 75(12):e14834. PubMed ID: 34510660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design.
    Buss VH; Shield A; Kosari S; Peterson GM; Naunton M
    Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluations of clinical pharmacy services: 2006-2010.
    Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
    Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study.
    Deibl S; Mueller D; Kirchdorfer K; Stemer G; Hoppel M; Weidmann AE
    Int J Clin Pharm; 2020 Aug; 42(4):1050-1060. PubMed ID: 32494989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary health care policy and vision for community pharmacy and pharmacists in Australia.
    Dineen-Griffin S; Benrimoj SI; Garcia-Cardenas V
    Pharm Pract (Granada); 2020; 18(2):1967. PubMed ID: 32477437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study.
    Salgado TM; Moles R; Benrimoj SI; Fernandez-Llimos F
    Int J Clin Pharm; 2012 Aug; 34(4):569-78. PubMed ID: 22538466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of major factors in Australian primary care pharmacists' practice environment that have a bearing on the implementation of professional models of practice.
    Jackson JK; Hussainy SY; Kirkpatrick CMJ
    Aust Health Rev; 2017 Aug; 41(4):378-383. PubMed ID: 27632343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.